Concepedia

Anil Sadarangani

AS

Statistics

Publications

19

Citations

1.4K

H-Index

16

Active since

2005

Affiliations

University of California San Diego(Current)

Pontificia Universidad Católica de Chile

Princess Margaret Cancer Centre

Canada's Michael Smith Genome Sciences Centre

BC Cancer Agency

Anil Sadarangani is an author at University of California San Diego specializing in oncology, molecular oncology, and medicine.

Publications per year

2005–2016

19

Publications

19

ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis

M Zipeto, Angela C. Court, Anil Sadarangani et al. · Cell stem cell · 2016 · 247 citations · Full text

, , +12

A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition

Daniel Goff, Angela C. Court, Anil Sadarangani et al. · Cell stem cell · 2013 · 195 citations · Full text

, , +16

ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia

Qingfei Jiang, Leslie Crews, Christian Barrett et al. · Proceedings of the National Academy of Sciences · 2012 · 191 citations · Full text

, , +17

Lipophilic but not hydrophilic statins selectively induce cell death in gynecological cancers expressing high levels of HMGCoA reductase.

Sumie Kato, Susan V. Smalley, Anil Sadarangani et al. · Journal of Cellular and Molecular Medicine · 2009 · 151 citations · Full text

, , +17

RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML

Leslie Crews, Larisa Balaian, Nathaniel P. Delos Santos et al. · Cell stem cell · 2016 · 121 citations · Full text

, , +12

1–5 of 19